Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EVEROLIMUS vs IMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EVEROLIMUS vs IMATINIB: Safety Overview

Metric EVEROLIMUS IMATINIB
Total FAERS Reports 39,640 43,161
Deaths Reported 8,374 13,761
Death Rate 21.1% 31.9%
Hospitalizations 11,211 7,264
Average Patient Age 53.4 yrs 55.7 yrs
% Female Patients 60.0% 47.2%
FDA Approval Date Apr 12, 2018 Apr 14, 2025
Manufacturer Amneal Pharmaceuticals NY LLC Dr.Reddy's Laboratories Inc
Route ORAL ORAL
Marketing Status Prescription Discontinued